Drug Type mRNA CAR-T |
Synonyms CRT 401, CRT401 |
Target |
Action modulators |
Mechanism HER2 modulators(Receptor tyrosine-protein kinase erbB-2 modulators), Trop-2 modulators(Tumor-associated calcium signal transducer 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glandular and Epithelial Neoplasms | Preclinical | United States | 01 Nov 2025 |





